Niemann-Pick disease type A: a case report
DOI:
https://doi.org/10.36408/mhjcm.v8i1.577Keywords:
Niemann-Pick disease type A, hepatosplenomegaly, failure to thriveAbstract
BACKGROUND
Niemann-Pick disease (NPD) types A result from the deficient activity of sphingomyelinase. NPD type A is characterized by early-onset, progressive neurodegenerative course; systemic disease manifestations, including massive hepatosplenomegaly, interstitial lung disease, and cherry-red macula; and death in early childhood. The objective: to enhance the recognition of health care providers about the potential undiagnosed NPD because nonspecific clinical manifestation
CASE PRESENTATION
A 18-months-old boy was admitted to Dr. Kariadi Hospital with enlarged abdomen since seventh month old with failure to thrive. He also showed progressive loss of neurologic function, microcephaly with open major fontanelle, recurrent pulmonary and systemic infection. Physical examination revealed facial dysmorphic, milestone regression, under-nutrition, crackles in both lungs, hepatosplenomegaly with petechial in extremities and floppy infants. Laboratory investigations showed anemia (9.4 g/dL) and thrombocytopenia (73.000/mm3). The lactate dehydrogenase (482 U/L) and alkaline phosphatase (159, 03 IU/L) were higher than normal. Abdominal ultrasound revealed hepatomegaly with normal parenchyma and splenomegaly without nodule. Skeletal survey revealed Erlenmeyer flask deformity. Foam cell are detected in bone marrow puncture. Retcam examination showed cherry red spot at the macula. Bera revealed auditory neuropathy. The enzyme activity showed normal ?–Glucosidase (5.55 uM/hr) and chitotriosidase (105,8 nmol/ml) but low sphingomyelinases activity (0.30 uM/hr) which confirmed the diagnosis of NPD.
DISCUSSION
Niemann-Pick disease (NPD) types A result from the deficient activity of sphingomyelinase. NPD type A is characterized by early-onset, progressive neurodegenerative course; systemic disease manifestations, including massive hepatosplenomegaly, interstitial lung disease, and cherry-red macula; and death in early childhood. Type A is very rare and a severe infantile form with neurologic degeneration resulting in death usually by 3 years of age. No treatment available for type A and It’s a rare disease in Indonesia.
CONCLUSION
These investigations were able to diagnose this child as a NPD-Type A. Patient was closely monitored and symptomatic treatment was provided.
Downloads
References
2. Mane V, Joshi RT, Mane VP. Niemann pick disease-a case report. J Evol Medic Dental Sci. 2012;1(6):955-58.
3. Sutay NR, Choudhary D, Samariya P, Jha S, Gangul S. Niemann-pick disease type B-a case report. JMSCR. 2017;5(4):19732-6.
4. Shubhankar M, Sunil KA, Bikash RP, Shantanu KM. Niemann pick disease type A in an Infant: a case report. Sch Acad J Biosci. 2014;2(10):728-30.
5. Bari MI, Haque MI, Siddiqui AB, Hossain MA, Alam T. Niemann Pick Disease: A Case Report. TAJ: J Teachers Association. 2011;15(1):32-4.
6. National Institute of Neurological Disorders and Stroke. (NINDS). Niemann Pick Disease Information Page. Available at https://www.ninds.nih.gov/Disorders/All-Disorders /Niemann-Pick-Disease-Information-Page.
7. Gregory M. Pasteres, Edwin H. Kolodny-lysosomal storage disease. In: Kenneth F. Swaiman, Stephen Ashwal, Donna M. Ferriero editors-Pediatric Neurology: Principleand Practice. 2006:1(4)673677.
8. Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM. Reversal of defectively sosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in then pc1-/- mouse. Proc Natl Acad Sci. 2009;106(7):2377-82.
9. Sriram S, Ahmed J, Saminathan S, Annie S, Raj S. Case study on type A Niemann pick disease. 2016;11(4):36-8.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2021 Medica Hospitalia : Journal of Clinical Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
